Export file:


  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text


  • Citation Only
  • Citation and Abstract

Transgenic plants for the production of immunogenic proteins

Department of Biology, Faculty of Science, Çankırı Karatekin University, Çankırı, 18100, Turkey

The vaccines are very effective vehicles for the prevention of various diseases. The cost of production and the need of cold-chain limit the vaccination programs especially in low-income countries. Hence, the plants offer a suitable platform to produce the immunogenic proteins with reduced cost without a requirement for cold-chain. The transgenic plants expressing antigens might be either used for the purification of the recombinant proteins or consumed as a food for the oral administration of the plant-based vaccine. A variety of plants have been used as the expression system, such as tobacco, rice, maize, carrot, soybean, potato and barley, each plant possessing pros and cons. Agrobacterium-mediated transformation, biolistics or electroporation techniques are used for the transformation of the plants, and the transgenic plants can be utilized for the development of vaccines against bacterial pathogens such as Mycobacterium tuberculosis, Bacillus anthracis, and viral diseases like Human Papillomavirus, Human Immunodeficiency Virus, as well as the diseases like cancer, synucleopathies or atherosclerosis.
  Article Metrics

Keywords plant-based vaccines; recombinant proteins; transgenic plants; vaccine development

Citation: Sezer Okay, Mehmet Sezgin. Transgenic plants for the production of immunogenic proteins. AIMS Bioengineering, 2018, 5(3): 151-161. doi: 10.3934/bioeng.2018.3.151


  • 1. Duclos P, Okwo-Bele JM, Gacic-Dobo M, et al. (2009) Global immunization: status, progress, challenges and future. BMC Int Health Hum Rights 9: S1–S2.    
  • 2. Kochhar S, Rath B, Seeber LD, et al. (2013) Introducing new vaccines in developing countries. Expert Rev Vaccines 12: 1465–1478.    
  • 3. Hernández M, Rosas G, Cervantes J, et al. (2014) Transgenic plants: a 5-year update on oral antipathogen vaccine development. Expert Rev Vaccines 13: 1523–1536.    
  • 4. Lugade AA, Kalathil S, Heald JL, et al. (2010) Transgenic plant-based oral vaccines. Immunol Invest 39: 468–482.    
  • 5. Peters J, Stoger E (2011) Transgenic crops for the production of recombinant vaccines and anti-microbial antibodies. Hum Vaccines 7: 367–374.    
  • 6. Kim SH, Jang YS (2014) Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines. Exp Mol Med 46: e85.    
  • 7. Rosales-Mendoza S, Ríos-Huerta R, Angulo C (2015) An overview of tuberculosis plant-derived vaccines. Expert Rev Vaccines 14: 877–889.    
  • 8. Rubio-Infante N, Govea-Alonso DO, Alpuche-Solís ÁG, et al. (2012) A chloroplast-derived C4V3 polypeptide from the human immunodeficiency virus (HIV) is orally immunogenic in mice. Plant Mol Biol 78: 337–349.    
  • 9. Mamedov T, Chichester JA, Jones RM, et al. (2016) Production of functionally active and immunogenic non-glycosylated protective antigen from Bacillus anthracis in Nicotiana benthamiana by co-expression with peptide-N-glycosidase F (PNGase F) of Flavobacterium meningosepticum. PLoS One 11: e0153956.    
  • 10. Kehm R, Jakob NJ, Welzel TM, et al. (2001) Expression of immunogenic Puumala virus nucleocapsid protein in transgenic tobacco and potato plants. Virus Genes 22: 73–83.    
  • 11. Lamphear BJ, Jilka JM, Kesl L, et al. (2004) A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine. Vaccine 22: 2420–2424.    
  • 12. Joensuu JJ, Kotiaho M, Teeri TH, et al. (2006) Glycosylated F4 (K88) fimbrial adhesin FaeG expressed in barley endosperm induces ETEC-neutralizing antibodies in mice. Transgenic Res 15: 359–373.    
  • 13. Wu J, Yu L, Li L, et al. (2007) Oral immunization with transgenic rice seeds expressing VP2 protein of infectious bursal disease virus induces protective immune responses in chickens. Plant Biotechnol J 5: 570–578.    
  • 14. Rao JP, Agrawal P, Mohammad R, et al. (2012) Expression of VP1 protein of serotype A and O of foot-and-mouth disease virus in transgenic sunnhemp plants and its immunogenicity for guinea pigs. Acta Virol 56: 91–99.    
  • 15. Vimolmangkang S, Gasic K, Soria-Guerra R, et al. (2012) Expression of the nucleocapsid protein of Porcine Reproductive and Respiratory Syndrome Virus in soybean seed yields an immunogenic antigenic protein. Planta 235: 513–522.    
  • 16. Uvarova EA, Belavin PA, Permyakova NV, et al. (2013) Oral Immunogenicity of plant-made Mycobacterium tuberculosis ESAT6 and CFP10. Biomed Res Int 2013: 316304.
  • 17. Kim MY, Kim TG, Yang MS (2017) Production and immunogenicity of Actinobacillus pleuropneumoniae ApxIIA protein in transgenic rice callus. Protein Expres Purif 132: 116–123.    
  • 18. Rosales-Mendoza S, Soria-Guerra RE, Moreno-Fierros L, et al. (2011) Immunogenicity of nuclear-encoded LTB:ST fusion protein from Escherichia coli expressed in tobacco plants. Plant Cell Rep 30: 1145–1152.    
  • 19. Shoji Y, Jones RM, Mett V, et al. (2013) A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge. Hum Vaccines 9: 553–560.    
  • 20. Hassan SW, Waheed MT, Müller M, et al. (2014) Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine. Hum Vaccin Immunother 10: 2975–2982.    
  • 21. Salazar-Gonzalez JA, Rosales-Mendoza S, Romero-Maldonado A, et al. (2014) Production of a plant-derived immunogenic protein targeting ApoB100 and CETP: toward a plant-based atherosclerosis vaccine. Mol Biotechnol 56:1133–1142.    
  • 22. Arevalo-Villalobos JI, Govea-Alonso DO, Monreal-Escalante E, et al. (2017) LTB-Syn: a recombinant immunogen for the development of plant-made vaccines against synucleinopathies. Planta 245: 1231–1239.    
  • 23. Matić S, Quaglino E, Arata L, et al. (2016) The rat ErbB2 tyrosine kinase receptor produced in plants is immunogenic in mice and confers protective immunity against ErbB2+ mammary cancer. Plant Biotechnol J 14: 153–159.    
  • 24. Chawla HS (2002) Introduction to Plant Biotechnology, 2 Eds., New Hampshire: Science Publishers.
  • 25. Noris E, Poli, A, Cojoca R, et al. (2011) A human papillomavirus 8 E7 protein produced in plants is able to trigger the mouse immune system and delay the development of skin lesions. Arch Virol 156: 587–595.    
  • 26. Korth K (2008) Genes and traits of interest for transgenic plants. In: Steward CN, Plant Biotechnology and Genetics: Principles, Techniques and Applications, 1 Eds., New Jersey: Wiley, 210–230.
  • 27. Finer J, Dhillon T (2008) Transgenic plant production. In: Steward CN, Plant Biotechnology and Genetics: Principles, Techniques and Applications, 1 Eds., New Jersey: Wiley, 245–272.
  • 28. De Block M, Herrera-Estrella L, van Montagu M, et al. (1984) Expression of foreign genes in regenerated plants and their progeny. EMBO J 3: 1681–1689.    
  • 29. Horsch RB, Fraley RT, Rogers SG, et al. (1984) Inheritance of functional foreign genes in plants. Science 223: 496–498.    
  • 30. Paszkowski J, Shillito RD, Saul M, et al. (1984) Direct gene transfer to plants. EMBO J 3: 2717–2722.    
  • 31. Tzfira T, Citovsky V (2006) Agrobacterium-mediated genetic transformation of plants: biology and biotechnology. Curr Opin Biotech 17: 147–154.    
  • 32. Sanford JC, Klein TM, Wolf ED, et al. (1987) Delivery of substances into cells and tissues using a particle bombardment process. Particul Sci Technol 5: 27–37.    
  • 33. Kikkert JR, Vidal JR, Reisch BI (2005) Stable transformation of plant cells by particle bombardment/biolistic. In: Pena L, Transgenic Plants Methods and Protocols, 1 Eds., New Jersey: Humana Press, 61–78.
  • 34. Yao Q, Cong L, Chang JL, et al. (2006) Low copy number gene transfer and stable expression in a commercial wheat cultivar via particle bombardment. J Exp Bot 57: 3737–3746.    
  • 35. Sanford JC (2000) The development of the biolistic process.Vitro Cell Dev-Pl 36: 303–308.    
  • 36. Srivastava V, Ow D (2001) Biolistic mediated site-specific integration in rice. Mol Breeding 8: 345–350.
  • 37. Fisk HJ, Dandekar AM (2005) Electroporation Introduction and expression of transgenes in plant protoplasts. In: Pena L, Transgenic Plants Methods and Protocols, 1 Eds., New Jersey: Humana Press, 79–90.
  • 38. Sidorov VA, Kasten D, Pang SZ, et al. (1999) Stable chloroplast transformation in potato: use of green fluorescent protein as a plastid marker. Plant J 19: 209–216.    
  • 39. Adem M, Beyene D, Feyissa T (2017) Recent achievements obtained by chloroplast transformation. Plant Methods 13: 30.    
  • 40. Larosa V, Remacle C (2013) Transformation of the mitochondrial genome. Int J Dev Biol 57: 659–665.    
  • 41. Chuah JA, Yoshizumi T, Kodama Y, et al. (2015) Gene introduction into the mitochondria of Arabidopsis thaliana via peptide-based carriers. Sci Rep 5: 7751.    
  • 42. Kalbina I, Lagerqvist N, Moiane B, et al. (2016) Arabidopsis thaliana plants expressing Rift Valley fever virus antigens: Mice exhibit systemic immune responses as the result of oral administration of the transgenic plants. Protein Expres Purif 127: 61–67.    
  • 43. Gunn KS, Singh N, Giambrone J, et al. (2012) Using transgenic plants as bioreactors to produce edible vaccines. J Biotech Res 4: 92–99.
  • 44. Wigdorovitz A (2005) Transgenic plants for the production of veterinary vaccines. Immunol Cell Biol 83: 229–238.    
  • 45. Lim MAG (2007) Transgenic plants in therapeutically valuable protein production. Transgentic Plant J 1: 256–266.
  • 46. Liew PS, Hair-Bejo M (2015) Farming of plant-based veterinary vaccines and their applications for disease prevention in animals. Adv Virol 2015: 936940.
  • 47. Pepponi I, Diogo GR, Stylianou E, et al. (2014) Plant-derived recombinant immune complexes as self-adjuvanting TB immunogens for mucosal boosting of BCG. Plant Biotechnol J 12: 840–850.    
  • 48. Lakshmi PS, Verma D, Yang X, et al. (2013) Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro. PLoS One 8: e54708.    
  • 49. Orellana-Escobedo L, Rosales-Mendoza S, Romero-Maldonado A, et al. (2015) An Env-derived multi-epitope HIV chimeric protein produced in the moss Physcomitrella patens is immunogenic in mice. Plant Cell Rep 34: 425–433.    
  • 50. Kessans SA, Linhart MD, Meador LR, et al. (2016) Immunological characterization of plant-based HIV-1 Gag/Dgp41 virus-like particles. PLoS One 11: e0151842.    
  • 51. Pineo CB, Hitzeroth II, Rybicki EP (2013) Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras. Plant Biotechnol J 11: 964–975.    
  • 52. Yang Y, Li X, Yang H, et al. (2011) Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants. Sci China Life Sci 54: 82–89.    
  • 53. Inka Borchers AM, Gonzalez-Rabade N, Gray JC (2012) Increased accumulation and stability of rotavirus VP6 protein in tobacco chloroplasts following changes to the 5' untranslated region and the 5' end of the coding region. Plant Biotechnol J 10: 422–434.    
  • 54. Voepel N, Boes A, Edgue G, et al. (2014) Malaria vaccine candidate antigen targeting the pre-erythrocytic stage of Plasmodium falciparum produced at high level in plants. Biotechnol J 9: 1435–1445.    


This article has been cited by

  • 1. Kiran Saba, Muhammad Sameeullah, Asba Asghar, Johanna Gottschamel, Sara Latif, Andreas Günter Lössl, Bushra Mirza, Osman Mirza, Mohammad Tahir Waheed,  Expression of ESAT‐6 antigen from Mycobacterium tuberculosis in broccoli: An edible plant , Biotechnology and Applied Biochemistry, 2020, 10.1002/bab.1867

Reader Comments

your name: *   your email: *  

© 2018 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Export Citation

Copyright © AIMS Press All Rights Reserved